Nastech Pharmaceutical Company Inc

Datamonitor's Nastech Pharmaceutical Company Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Nastech Pharmaceutical (Nastech) is engaged in a variety of preclinical and clinical research and development activities to identify and develop viable product candidates in therapeutic areas, including osteoporosis, obesity, diabetes, autism, antivirals, inflammation and metabolic diseases. Nastech is headquartered in Bothell, Washington and employs 197 people as of December 2006. *The company recorded revenues of $18.1 million during the fiscal year ended December 2007, a decrease of 36.3% compared to 2006. The operating loss of the company was $54.5 million during fiscal year 2007, as compared to an operating loss of $29.3 million in 2006. The net loss was $52.4 million in fiscal year 2007, as compared to the net loss of $26.9 million in 2006. *Unaudited results

Scope of the Report

• Provides all the crucial company information required for business and competitor intelligence needs
• Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

• Support sales activities by understanding your customers' businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors' business structure, strategy and prospects
• Obtain the most up to date company information available